| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $800.9M | +11.6% |
| Cost of Revenue | $444.5M | +9.0% |
| Gross Profit | $356.4M | +14.9% |
| R&D Expense | $31.7M | +4.6% |
| SG&A Expense | $340.1M | -6.1% |
| Operating Income | -$21.9M | +92.6% |
| Pre-tax Income | -$105.3M | +65.7% |
| Income Tax | -$6.6M | +63.7% |
| Net Income | -$96.9M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $128.8M | +75.2% |
| Accounts Receivable | $172.3M | +0.6% |
| Inventory | $144.1M | +0.6% |
| Current Assets | $538.6M | +12.1% |
| Total Assets | $2.72B | -0.7% |
| Current Liabilities | $265.7M | +8.8% |
| Long-term Debt | $685.9M | -15.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $95.2M | +141.6% |
| Capital Expenditures | $37.1M | +8.5% |
| Investing Cash Flow | -$64.7M | -63.8% |
| Financing Cash Flow | $22.6M | +422.9% |
| Free Cash Flow | $58.1M | +1017.3% |
| +65.0% |
| EPS (Basic) | -$0.49 | +68.0% |
| EPS (Diluted) | -$0.49 | +68.0% |
| Total Liabilities |
| $1.17B |
| -8.1% |
| Stockholders' Equity | $1.48B | +6.2% |